Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department
- Conditions
- Covid19SARS-CoV Infection
- Registration Number
- NCT04779021
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
The main objective of this cohort is to characterize COVID-19 patients hospitalized in infectious disease department. The collection of clinical and biological data from start of hospitalization to long-term follow up will contribute to a better description of the patient care, to the identification of predisposition to complication related to the disease, and to the evaluation of the impact of different therapeutical strategies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1300
- Age > or = to 18
- Patients hospitalised for SARS-CoV-2 infection confirmed by RT PCRand/or CT scan and/or serology
- Patients for whom SARS-CoV-2 infection has not been confirmed
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical characteristics 34 months Describe the clinical characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity
Biological characteristics 34 months Describe the biological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity
Radiological characteristics 34 months Describe the radiological characteristic of patients hospitalized for SARS-CoV- 2 infection Identify factors associated with the COVID-19 disease severity
- Secondary Outcome Measures
Name Time Method ICU Length of Stay (LOS) 34 months Duration measured in days
Overall Inpatient Mortality 34 months Number of death due to Covid-19
Requirement for mechanical ventilation 34 months Number of patients requiring mechanical ventilation
Evolution of patient general state during hospitalisation 34 months the different measures (Body Mass Index (BMI), respiratory rate at rest, peripheral oxygen saturation, need for oxygen supplementation, body temperature) will be aggregated in order to obtain a clinical status corresponding to the clinical evolution (good or bad) of the patient's general state.
Biological tests 34 months Dosage of Lymphocytes, C-reactive protein and IL-6
Number of patient hospitalised for Covid-19 34 months Inpatient up to Day 28 or discharge
Trial Locations
- Locations (2)
CHU de NICE - Urgences
馃嚝馃嚪Nice, France
CHU de NICE - Infectiologie
馃嚝馃嚪Nice, France